Mass drug administration coverage evaluation survey for lymphatic Filariasis in Bagalkot and Gulbarga districts

Indian Journal of Community Medicine

Volumn 37, Issue 2, 2012, Pages 101-106

  Patel, Prakash Kurubarahalli ^a  

^a SRI DEVARAJ URS MEDICAL COLLEGE   (India)

Author keywords

Albendazole; diethylcarbamazine; evaluation; India; lymphatic filariasis; mass drug administration; survey

Indexed keywords

EID: 84861306535     PISSN: 09700218     EISSN: 19983581     Source Type: Journal    
DOI: 10.4103/0970-0218.96095     Document Type: Article

References (23)

1. Krentel A, Fischer P, Manoempil P, Supali T, Servais G, Rückert P. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia. Trop Med Int Health 2006;11:1731-40.
2. World Health Organization. Life in the 21st century: A vision for all. The World Health Report 1998. Available from: http://www.who.int/whr/1998/en/ whr98 en.pdf. [Last accessed on 2010 Apr 15].
3. World Health Organization. Regional Strategic Plan for Elimination of Lymphatic Filariasis (2004-2007) 2004; 1-2. Available from: http://www.searo. who.int/LinkFiles/New Lymphatic Filariasis-Regional-Strategic-Plan-LF 2004-2007. pdf. [Last accessed on 2010 Apr 20].
4. World Health Organization. Lymphatic Filariasis. Weekly Epidemiol Rec 2007;82:361-80. Available from: http://www.who. int/wer/2007/wer8242.pdf. [Last accessed on 2010 Apr 20].
5. World Health Organization. Lymphatic Filariasis. Monitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level. Available from: http://whqlibdoc.who.int/hq/2005/ WHO-CDS-CPE-CEE-2005.50.pdf. [Last accessed on 2010 Apr 18].
6. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999;15:382-6.
7. National Health Policy 2002. New Delhi: Ministry of Health and Family Welfare, Government of India 2002. p. 1-39.
8. World Health Organization. Preparing and Implementing a National Plan to Eliminate Lymphatic filariasis in countries where Onchocerciasis is not co-endemic. Available from: http://whqlibdoc.who.int/hq/2000/WHO-CDS-CPE-CEE- 2000.15.pdf. [Last accessed on 2010 Apr 15].
9. El Setouhy M, Ramzy RM, Ahmed ES, Kandil AM, Hussain O, Farid HA, et al. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. Am J Trop Med Hyg 2004;70:191-6.
10. Ranganath BG. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India. J Vector Borne Dis 2010;47:61-4.
11. Government of India. Operational guidelines on elimination of lymphatic filariasis. Directorate NVBDCP, 22 Shamnath Marg, Delhi 110 054, 2005. p. 3. Available from: http://www.nvbdcp.gov.in/Doc/LF%20manual-final.doc [Last accessed on 2012 Apr 15].
12. Das PK, Pani SP, Krishnamoorthy K. Prospects of elimination of lymphatic filariasis in India. Icmr Bull 2002;32:41-54.
13. Aswathy S, Beteena K, Leelamoni K. Mass drug administration against filariasis in India: Perceptions and practices in a rural community in Kerala. Ann Trop Med Parasitol 2009;103: 617-24.
14. Babu BV, Rath K, Kerketta AS, Swain BK, Mishra S, Kar SK. Adverse reactions following mass drug administration during the programme to eliminate lymphatic filariasis in Orissa state, India. Trans R Soc Trop Med Hyg 2006;100:464-9.
15. Nandha B, Sadanandane C, Jambulingam P, Das P. Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience. Filaria J 2007;6:7.
16. Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: An evaluation study. J Vector Borne Dis 2008;45:313-20.
17. Kumar P, Prajapati P, Saxena D, Kavishwar AB, Kurian G. An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat, India. Indian J Community Med 2008;33:38-42.
18. Babu BV, Kar SK. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Trop Med Int Health 2004;9:702-9.
19. USAID. Post MDA Survey Design: Monitoring treatment coverage of neglected disease control programs 2009. Available from: http://www.neglecteddiseases. gov/resources/tools guidelines/mda-survey.pdf. [Last accessed on 2010 Apr 15].
20. Sunish IP, Rajendran R, Mani TR, Munirathinam A, Tewari SC, Hiriyan J, et al. Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia- A longitudinal study. Trop Med Int Health 2002;7:59-69.
21. Sunish IP, Rajendran R, Mani TR, Munirathinam A, Dash AP, Tyagi BK. Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India. Bull World Health Organ 2007;85:138-45.
22. Mukhopadhyay AK, Patnaik SK, Satya Babu P, Rao KN. Knowledge on lymphatic filariasis and mass drug administration programme in filarial endemic districts of Andhra Pradesh, India. J Vector Borne Dis 2008;45:73-5.
23. Ramaiah KD, Das PK, Vanamail P, Pani SP. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health 2003;8:1082-92.